The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

MARKET PULSE-Solar stocks, Uranium stocks, Saks, Intersil, Prana Biotech

Mon, 29th Jul 2013 17:27

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://r.reuters.com/ref99t)

July 29 (Reuters) - Some U.S. stocks on the move on Monday:

WALL STREET FALLS AS INVESTORS EYE FED STATEMENT

U.S. stocks fell as investor sentiment turned wary before aU.S. Federal Reserve meeting later this week that could signalwhen the Fed will begin to temper its ultra accomodative policy.The Dow Jones Industrial Average was down 64.15 points,or 0.41 percent. The Standard & Poor's 500 Index fell8.41 points, or 0.50 percent, and the Nasdaq Composite Index lost 17.67 points, or 0.49 percent.

** USEC INC, $26.80, up 40 pct (1225 ET)

** LIGHTBRIDGE CORP, $2.12, up 33 pct (1225 ET)

** URANIUM RESOURCE INC, $5.02, up 21 pct (1225 ET)

Stocks of nuclear fuel companies soared after there-election of Japan's Liberal Democratic Party. The rulingparty is keen to get reactors running again, with Prime MinisterShizo Abe singling out reining in soaring fuel costs as a keypart of his economic reform plans.

** SYNTA PHARMACEUTICALS CORP, $6.88, up 36 pct(1253 ET)

The biopharmaceutical company said a proof-of-concept studyon its drug candidate ganetespib as a treatment for breastcancer has met its goal. Preliminary data showed the study couldnow be expanded and taken to its next stage, the company said.

Roth Capital Partners, which raised its price target on thestock to $20 from $18, said Synta remained attractive basedprimarily on the promise of ganetespib in several oncologyindications.

** CHANGYOU.COM LTD, $32.87, down 19.91 pct (1310ET)

The Chinese online game developer reportedlower-than-expected second-quarter revenue and forecastcurrent-quarter results below analysts' estimates.

** PRANA BIOTECHNOLOGY , $3.78, up 15 pct(1230 ET)

The Australian company said that the first patient has beendosed in a mid-stage study testing its experimental Alzheimer'sDisease drug.

** TURQUOISE HILL RESOURCES LTD, $4.64, down 13 pct(1223 ET)

The company's largest shareholder, Rio Tinto, hasput on hold all work on an underground expansion of the OyuTolgoi copper mine in Mongolia after the government said theparliament will need to approve financing for the project, whichis expected to cost more than $5 billion.

Oyu Tolgoi is 66 percent owned by Turquoise Hill unit, and 34 percent owned by the Mongolian government.

** YRC WORLDWIDE INC, $28.33, down 10 pct (1252 ET)

Credit Suisse started coverage on the stock of thetransportation and logistics company with an "underperform"rating.

** HAEMONETICS CORP, $41.45, down 9 pct (1252 ET)

The company, which provides devices, information managementand consulting services related to the collection andtransfusion of blood, reported first-quarter revenue that missedanalysts' estimates due to lower-than-expected surgical blooduse and lower blood collection.

It cut its revenue forecast by two percentage points, citingweak market conditions.

SOLAR STOCKS

** SUNTECH POWER HOLDINGS CO LTD, $1.47, up 4 pct(1251 ET)

** RENESOLA LTD, $4.54, up 6 pct (1254 ET)

** JINKOSOLAR HOLDING CO LTD, $14.01, up 9 pct (1252ET)

** CANADIAN SOLAR INC, $14.01, up 2 pct (1254 ET)

** TRINA SOLAR LTD, $7.58, up 2 pct (1256 ET)

China and the European Union defused their biggest tradedispute by far on Saturday with a deal to regulate Chinese solarpanel imports and avoid a wider war in goods from wine to steel.

EU's trade chief and his Chinese counterpart set a minimumprice for panels from China near spot market prices. Under theterms of the deal, China will also be allowed to meet about halfEurope's solar panel demand, if taken at last year's levels.

"The latest agreement more or less maintains the status quofor Chinese module makers," Raymond James analyst PavelMolchanov said, adding that the deal was in line withexpectations.

Chinese firms have already been bracing themselves for lowersales to Europe because the European market size is shrinking,while increasing their presence in markets like China and Japan.

** SOHU.COM INC, $62.66, down 10 pct (1256 ET)

The Chinese Internet portal reported second-quarter revenueslightly below analysts' estimates and forecast current-quarterprofit below Wall Street's expectation.

** SPHERIX INC, $7.27, up 6 pct (1251 ET)

The company disclosed terms of its previously announced dealto buy seven patents in the mobile communication sector fromprivately-held Rockstar Consortium.

Under the terms of the agreement, Spherix paid anunspecified amount of cash up-front and issued common stockvalued at $1 million.

** WET SEAL INC, $4.47, down 4 pct (1257 ET)

Brokerage B. Riley & Co downgraded the teen-apparelretailer's stock to "neutral", according to Theflyonthewall.com.

** FRANCESCA'S HOLDINGS CORP, $26.01, down 5 pct(1211 ET)

Wedbush Securities Inc cut its rating on the women's apparelretailer's stock to "neutral" from "outperform" due tolackluster mall traffic and competition as well as stagnatingmargins.

** INTERPUBLIC GROUP OF COS, $16.60, up 5 pct (1257ET)

** OMNICOM GROUP, $65.60, up 1 pct (1258 ET)

Following a Bloomberg report that bigger rivals OmnicomGroup and Publicis Groupe were in talks for a merger, shares of Interpublic rose on expectation the secondlargest U.S. advertising company would be in play.

Omnicom and Publicis announced on Sunday that they wouldmerge in a $35.1 billion deal.

Interpublic may be considered an acquisition target by WPP, Havas or Japan-based Dentsu, PivotalResearch Group analyst Brian Wieser wrote in a note on Sunday.

** CHELSEA THERAPEUTICS INTERNATIONAL LTD, $2.96,down 4 pct (1258 ET)

Chelsea Therapeutics said the U.S. Food and DrugAdministration has notified the pharmaceutical company offormatting issues in certain electronic datasets andstatistical programs submitted as a part of the marketingapproval application of its experimental hypotension drug,Northera.

Chelsea expects to submit the data in August. The date for adecision on the drug's approval may be delayed from thepreviously decided date of Jan. 3, 2014.

** NOVAVAX INC, $2.55, up 3 pct (1258 ET)

The vaccine developer reported positive results frompre-clinical studies testing its experimental vaccine againstthe H7N9 virus, a strain of the bird flu virus.

Novavax said the drug demonstrated 100 percent protectionagainst wild-type A (H7N9) influenza versus zero percentsurvival in the control and placebo groups, when tested on mice.

The virus has caused 36 deaths, and infected 131 people inmainland China and one in Taiwan since February.

** INTUITIVE SURGICAL INC, $388.93, up 2 pct (1259ET)

The maker of da Vinci surgical robots said it wouldrepurchase additional $779 million of the company's outstandingcommon stock. Intuitive's total share repurchase amount will nowbe about $1.5 billion.

** INTERSIL CORP, $9.23, up 5 pct (1259 ET)

The company, which makes power management chips used inflat-panel displays and DVD players, reportedbetter-than-expected second-quarter revenue on Friday. Intersilalso said it will reduce its workforce by 150 employees.

** SAKS INC, $15.84, up 3 pct (1259 ET)

Hudson's Bay Co, operator of department storechains Lord & Taylor in the United States and The Bay in Canada,said on Monday that it would buy luxury retailer Saks Inc for$16 per share, or $2.9 billion in cash, including debt.

** SUMITOMO MITSUI FINANCIAL GROUP INC, $9.39, up 2pct (1257 ET)

The bank said its quarterly net profit more than doubled asa rally in Japanese stocks pushed up the value of its equityinvestments and boosted profit at its brokerage unit.

** HORMEL FOODS CORP, $42.22, up 2 pct (1300 ET)

Credit Suisse upgraded the stock of the maker of Spam cannedham to "outperform" from "neutral", saying it expectssignificant margin expansion in the company's turkey and porkbusiness due to lower feed and packing costs.

The brokerage also raised its price target on the stock to$46 from $39. Credit Suisse expects Hormel's Skippy peanutbutter acquisition to exceed the company's own accretion targetsas sales growth are seen accelerating.

** LINCOLN ELECTRIC HOLDINGS INC, $58.60, down 4pct (1300 ET)

The maker of welding and cutting equipments reportedlower-than-expected quarterly revenue, hurt by lower sales inEurope and Asia Pacific. Sales at its largest North Americasegment rose only marginally.

** HOLLYFRONTIER CORP, $45.37, up 2 pct (1301 ET)

Shares of the Dallas-based oil refiner are expected to rise30 percent over the medium term as the company has access tocheaply-priced crude produced in North Dakota, West Texas, andthe Rocky Mountain region, weekly business newspaper Barron'sreported on Sunday.

** BARNES & NOBLE INC, $17.52, down 5 percent (1301ET)

The top U.S. bookstore chain said it sought more time todeliver audited financial statements to lenders due torestatements in certain financial periods. (http://link.reuters.com/nef99t)

The company said it had to restate certain financialstatements for periods prior to April 27, 2013, as it hadoverstated certain accruals as a result of inadequate controlsover the accrual reconciliation process at its distributioncenters.

** HERTZ GLOBAL HOLDINGS INC $26.21, down 3 pct(1302 ET)

The car rental company's CEO Mark Frissora said airportdemand was being impacted by the sequester and by airlinecapacity constraints and the associated higher fares. Thecompany's second quarter profit of 45 cents met Wall Street'sestimates, according to Thomson Reuters I/B/E/S.

** WYNN RESORTS LTD, $131.09, down 0.1 pct (1303ET)

The casino resorts operator reported a 6 percent drop inquarterly profit, hurt by a loss on early retirement of debt.The company's second-quarter results also missed Wall Street'sestimates. (Compiled by Rohit T.K. in Bangalore; Editing by SreejirajEluvangal)

Related Shares

More News
25 Apr 2024 10:00

TOP NEWS: WPP holds guidance despite ongoing weakness in Asia and tech

(Alliance News) - WPP PLC on Thursday reported a fall in first quarter sales as progress in Europe was offset by declines in Asia.

25 Apr 2024 07:41

WPP Q1 revenues fall 1.4%; Guidance held

(Sharecast News) - UK advertising agency WPP on Thursday said revenues fell 1.4% as it lost a healthcare client and spending by technology companies w...

25 Apr 2024 07:26

Ad group WPP reports 1.6% drop in first-quarter organic growth

LONDON, April 25 (Reuters) - British ad group WPP reported a 1.6% drop in organic growth in the first quarter, lagging its major rivals, after it wa...

18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

10 Apr 2024 11:56

LONDON MARKET MIDDAY: European stocks get boost ahead of US inflation

(Alliance News) - Stock prices in London were higher at midday on Wednesday, despite some nerves centred around the latest US inflation rate reading, ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.